1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma
(
- Contribution to journal › Article
- 2022
-
Mark
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
(
- Contribution to journal › Article
- 2021
-
Mark
Variations in the management of diffuse low-grade gliomas - A Scandinavian multicenter study
(
- Contribution to journal › Article
- 2018
-
Mark
A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)
(
- Contribution to journal › Article
-
Mark
Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer : Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial
(
- Contribution to journal › Article
- 2017
-
Mark
Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
Vaccination and allergy : EAACI position paper, practical aspects
2017) In Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 28(7). p.628-640(
- Contribution to journal › Scientific review
- 2016
-
Mark
Regulation of the germinal center response by T follicular helper cells and type I interferons
2016)(
- Thesis › Doctoral thesis (compilation)
- 2015
-
Mark
Tamoxifen treated patients have a better survival than patients treated with aromatase inhibitors - A population based registry study in Sweden
(
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
Adjuvant therapy in primary GIST: state-of-the-art
(
- Contribution to journal › Scientific review